Use of dipyridamole, acetylsalicylic acid and an angiotensin II antagonist for treatment and prevention of vascular events

Details for Australian Patent Application No. 2003235004 (hide)

Owner Boehringer Ingelheim Pharma GmbH & Co. KG

Inventors Hilbrich, Lutz; Humphreys, David Michael; Gilbert, James C.; Riedel, Axel

Agent Davies Collison Cave

Pub. Number AU-A-2003235004

Filing date 13 August 2003

Wipo publication date 3 March 2005

International Classifications

A61K 031/616

A61P 009/10 Drugs for disorders of the cardiovascular system

A61K 031/4184

A61K 031/519 - ortho- or peri-condensed with heterocyclic rings

A61P 007/02 Drugs for disorders of the blood or the extracellular fluid

Event Publications

28 August 2003 Complete Application Filed

3 March 2005 Application Open to Public Inspection

  Published as AU-A-2003235004

11 March 2010 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(d). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2003235005-Antibodies to non-functional P2X7 receptor diagnosis and treatment of cancers and other conditions

2003235003-Insulation system